Given that Mr Meng recently quit his deputy GM position of...

Given that Mr Meng recently quit his deputy GM position of Sihuan Pharma - a $24 Billion HK, Hong Kong listed China based pharmaceutical company, then turned his eye and personal money to take up stock in Uscom Australia, it seems logical to assume that he has plans for this business. He removed a conflict of interest with Sihuan Pharma, and such freedom now provides him with open access to all of China's 10.000 hospitals. Also, right now he appears to have a 13% holding in this business. However London to a brick that stake will grow. Right now there's 11 sellers of UCM in the entire world, with a mere 500,000 units to vend - Stacked up against 30 punters wanting to buy 36,000,000 shares. Tells a story of what comes next if the demand side of the ownership of the business grows - Doesn't it !